Modified technique for frontal sinus obliteration using calvarial bone and Tisseel glue.
BACKGROUND
Frontal sinus obliteration is indicated in trauma and frontal sinus disease. We present our experience with a modified technique of frontal sinus obliteration.


METHODS
We reviewed the records of 17 patients who underwent frontal sinus obliteration with a combination of Tisseel fibrin glue (Baxter Healthcare Corporation, Deerfield, IL) and calvarial bone and describe our technique.


RESULTS
One female and 16 male patients (mean age, 36.6) underwent frontal sinus obliteration from 2001 to 2005. Traumatic fracture was the most common indication. The patients were followed up for a median of 15 months. There were no major complications. Postoperatively, one patient developed a localized frontal wound infection at 3 weeks; this resolved with debridement. At latest follow-up, all were free from local sinus complications, disease recurrence, headaches, or intracranial events.


CONCLUSIONS
The combined use of autogenous calvarial bone and Tisseel is suitable for frontal sinus obliteration. Our technique is associated with low donor site morbidity, avoids a separate donor surgical site, and has a low complication rate.
Kang
Gavin Chun-Wui
GC
Department of Plastic, Reconstructive and Aesthetic Surgery, Singapore General Hospital, Singapore City, Singapore.
Sng
Karen Wei-Ee
KW
Tay
Andrew George
AG
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016025:Bone Transplantation / Q000379:methods*; D003646:Debridement; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000627:therapeutic use*; D005500:Follow-Up Studies; D018460:Fractures, Comminuted / Q000601:surgery; D005626:Frontal Sinus / Q000293:injuries / Q000601:surgery*; D015522:Frontal Sinusitis / Q000601:surgery; D006801:Humans; D004204:Joint Dislocations / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009078:Mucocele / Q000601:surgery; D012189:Retrospective Studies; D012887:Skull Fractures / Q000601:surgery; D013530:Surgical Wound Infection / Q000209:etiology; D014014:Tissue Adhesives / Q000627:therapeutic use*; D055815:Young Adult
D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives